September 2018
Prostate Cancer Screening Is Controversial
September 21, 2018
Article
From the Chairman
This letter from the Chairman and CEO of Oncology Nursing News gives an overview of the contents of the September 2018 print issue of the magazine.
Impact of Goals of Care on Resource Use at End of Life
September 13, 2018
Article
Partner Perspectives
Researchers exam­ined whether there were differences in resource use at end of life between patients with advanced cancer who identified goals of care focused heavily upon survival versus those who identified goals of care heavily focused on quality of life.
Glutaminase Inhibitor That Starves Tumor Cells May Improve Survival in Metastatic RCC
September 11, 2018
Article
Clinical Trials in Progress
A novel glutaminase inhibitor, CB-839, may provide a survival benefit in combination with cabozantinib (Cabometyx) by cutting off the energy supply to tumor cells in patients with metastatic renal cell carcinoma (RCC).
Novel RET Inhibitor Tested in Patients With NSCLC, MTC
September 11, 2018
Article
Clinical Trials in Progress
The phase I open-label LIBRETTO-001 clinical trial is currently testing LOXO-292, an oral small molecule inhibitor of RET signaling, to improve outcomes in patients with RET fusion–positive non–small cell lung cancer (NSCLC), medullary thyroid cancer (MTC), and other tumors with increased RET activity.
Celebrating Nurses All Year Long
September 10, 2018
Article
Professionally Speaking
Consistent recognition can improve morale and help organizations recruit and retain staff.
The Role of Volunteers in an Oncology Setting
September 08, 2018
Article
Fast Facts for the Frontline
Unpaid assistants can help nurses maximize their valuable time with patients.
The New MM: Medical Marijuana
September 07, 2018
Article
Nurse's Notes
What to know in responding to patients’ questions about benefits, risks, and access.
Pursuing a Calling: From Convent to Cancer Care
September 06, 2018
Article
Feature Story
How Kathleen Shannon Dorcy, PhD, RN, FAAN, became a leading voice in oncology nursing.
To Test or Not to Test? Pros, Cons, and the Promise of Genomics in Prostate Cancer
September 05, 2018
Article
Cover Story
There are still no simple answers to the question of screening for prostate cancer.
JAK Inhibition in Myelofibrosis Treatment May Cause Aggressive Lymphoma in Small Percentage of Patients
September 03, 2018
Article
Adverse Events Report
Although JAK inhibitors are a proven effective treatment for patients with myelofibrosis, a type of myeloproliferative neoplasm (MPN), they may come with a severe downside; in particular, a 16-fold increase in the chance of developing a B-cell lymphoma, according to recent research published in the journal Blood.